Prostate Cancer Clinical Trials in Florida

Showing 141-160 of 172 trials

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NCT02080689

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Prostate Cancer

GenomeDx Biosciences Corp286 participantsStarted May 2014

Anchorage, Alaska, United States • Los Angeles, California, United States • Aurora, Colorado, United States +16 more locations

COMPLETEDPhase 225 miles

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

NCT00087139

Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die. This phase II trial is studying how well ixabepilone works in treating patients with metastatic prostate cancer that has not responded to previous hormone therapy.

Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer

National Cancer Institute (NCI)124 participantsStarted Sep 2004

Aurora, Colorado, United States • Boulder, Colorado, United States • Colorado Springs, Colorado, United States +159 more locations

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer Trials in Other Cities

Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)

Multi-site Decision Impact Study for Decipher

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Pilot Study on Focal Prostate Radio-Frequency Ablation

3-AP in Treating Patients With Advanced Prostate Cancer

The Specific Role of Isoflavones in Reducing Prostate Cancer Risk

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

A Trial of Degarelix in Patients With Prostate Cancer

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Other Conditions in Florida